194 related articles for article (PubMed ID: 38172843)
1. Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysis.
Zhang W; Zhang Z; Qian L
World J Surg Oncol; 2024 Jan; 22(1):8. PubMed ID: 38172843
[TBL] [Abstract][Full Text] [Related]
2. Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis.
Ye Q; Cheng J; Ye M; Liu D; Zhang Y
J Gynecol Oncol; 2019 Jan; 30(1):e5. PubMed ID: 30479089
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of preoperative prognostic nutritional index in ovarian cancer: A systematic review and meta-analysis.
Dai Y; Liu M; Lei L; Lu S
Medicine (Baltimore); 2020 Sep; 99(38):e21840. PubMed ID: 32957308
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Role of the C-Reactive Protein/Albumin Ratio in Patients With Gynecological Cancers: A Meta-Analysis.
Fang Y; Zheng T; Zhang C
Front Oncol; 2021; 11():737155. PubMed ID: 34778051
[TBL] [Abstract][Full Text] [Related]
5. Correlation between NM23 protein overexpression and prognostic value and clinicopathologic features of ovarian cancer: a meta-analysis.
Fang J; Guo X; Zheng B; Han W; Chen X; Zhu J; Xie B; Liu J; Luan X; Yan Y; He Z; Li H; Qiao C; Yu J
Arch Gynecol Obstet; 2018 Feb; 297(2):449-458. PubMed ID: 29274004
[TBL] [Abstract][Full Text] [Related]
6. C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.
Yang Y; Li X; Qian H; Di G; Zhou R; Dong Y; Chen W; Ren Q
Comput Intell Neurosci; 2022; 2022():6833078. PubMed ID: 36268143
[TBL] [Abstract][Full Text] [Related]
7. Association between C-reactive protein level and subsequent risk of ovarian cancer: A meta-analysis of 13 cohorts in 1,852 ovarian cancer patients.
Wang Y; Zhang Z; Wang J; Zhang X
Medicine (Baltimore); 2020 Jan; 99(5):e18821. PubMed ID: 32000385
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
Tao Y; Li H; Huang R; Mo D; Zeng T; Fang M; Li M
Cell Physiol Biochem; 2018; 46(4):1716-1726. PubMed ID: 29730663
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysis.
Zhao L; Gu C; Huang K; Zhang Z; Ye M; Fan W; Han W; Meng Y
Arch Gynecol Obstet; 2016 Nov; 294(5):1019-1029. PubMed ID: 27300001
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological impacts of Controlling Nutritional Status (CONUT) score on patients with gynecological cancer: a meta-analysis.
Niu Z; Yan B
Nutr J; 2023 Jul; 22(1):33. PubMed ID: 37422623
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis.
Gong J; Jiang H; Shu C; Hu MQ; Huang Y; Liu Q; Li RF
J Ovarian Res; 2019 May; 12(1):51. PubMed ID: 31151469
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of C-reactive protein in patients with cervical cancer: a meta-analysis.
Yang S; Zhang Z; Shen L
Front Oncol; 2023; 13():1232409. PubMed ID: 37731642
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of programmed cell death ligand 1 expression in patients with ovarian carcinoma: A systematic review and meta-analysis.
Huang LJ; Deng XF; Chang F; Wu XL; Wu Y; Diao QZ
Medicine (Baltimore); 2018 Oct; 97(43):e12858. PubMed ID: 30412078
[TBL] [Abstract][Full Text] [Related]
15. The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis.
Chen Y; Cong R; Ji C; Ruan W
Cancer Med; 2020 Dec; 9(24):9541-9553. PubMed ID: 33201589
[TBL] [Abstract][Full Text] [Related]
16. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
[TBL] [Abstract][Full Text] [Related]
17. Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer.
Kodama J; Miyagi Y; Seki N; Tokumo K; Yoshinouchi M; Kobashi Y; Okuda H; Kudo T
Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):107-10. PubMed ID: 10192497
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis.
Zhou K; Li C; Chen T; Zhang X; Ma B
Front Endocrinol (Lausanne); 2023; 14():1111277. PubMed ID: 36817592
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: a meta-analysis.
Mao H; Yang F
Front Oncol; 2023; 13():1193962. PubMed ID: 37342198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
